JP2022505468A5 - - Google Patents

Info

Publication number
JP2022505468A5
JP2022505468A5 JP2021521511A JP2021521511A JP2022505468A5 JP 2022505468 A5 JP2022505468 A5 JP 2022505468A5 JP 2021521511 A JP2021521511 A JP 2021521511A JP 2021521511 A JP2021521511 A JP 2021521511A JP 2022505468 A5 JP2022505468 A5 JP 2022505468A5
Authority
JP
Japan
Prior art keywords
soluble
ecm
composition according
composition
pharmaceutical composition
Prior art date
Application number
JP2021521511A
Other languages
English (en)
Japanese (ja)
Other versions
JP7536004B2 (ja
JP2022505468A (ja
JPWO2020086955A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/058052 external-priority patent/WO2020086955A1/en
Publication of JP2022505468A publication Critical patent/JP2022505468A/ja
Publication of JP2022505468A5 publication Critical patent/JP2022505468A5/ja
Publication of JPWO2020086955A5 publication Critical patent/JPWO2020086955A5/ja
Priority to JP2024129889A priority Critical patent/JP2024166198A/ja
Application granted granted Critical
Publication of JP7536004B2 publication Critical patent/JP7536004B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021521511A 2018-10-25 2019-10-25 可溶性細胞外マトリックス組成物および血管内送達のための方法 Active JP7536004B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024129889A JP2024166198A (ja) 2018-10-25 2024-08-06 可溶性細胞外マトリックス組成物および血管内送達のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862750303P 2018-10-25 2018-10-25
US62/750,303 2018-10-25
PCT/US2019/058052 WO2020086955A1 (en) 2018-10-25 2019-10-25 Soluble extracellular matrix composition and method for intravascular delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024129889A Division JP2024166198A (ja) 2018-10-25 2024-08-06 可溶性細胞外マトリックス組成物および血管内送達のための方法

Publications (4)

Publication Number Publication Date
JP2022505468A JP2022505468A (ja) 2022-01-14
JP2022505468A5 true JP2022505468A5 (https=) 2022-08-19
JPWO2020086955A5 JPWO2020086955A5 (https=) 2022-08-19
JP7536004B2 JP7536004B2 (ja) 2024-08-19

Family

ID=70330739

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021521511A Active JP7536004B2 (ja) 2018-10-25 2019-10-25 可溶性細胞外マトリックス組成物および血管内送達のための方法
JP2024129889A Pending JP2024166198A (ja) 2018-10-25 2024-08-06 可溶性細胞外マトリックス組成物および血管内送達のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024129889A Pending JP2024166198A (ja) 2018-10-25 2024-08-06 可溶性細胞外マトリックス組成物および血管内送達のための方法

Country Status (7)

Country Link
US (1) US20210379245A1 (https=)
EP (1) EP3870192A4 (https=)
JP (2) JP7536004B2 (https=)
CN (1) CN112867499A (https=)
AU (1) AU2019363610B2 (https=)
CA (1) CA3117688A1 (https=)
WO (1) WO2020086955A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230364152A1 (en) * 2020-09-14 2023-11-16 The Regents Of The University Of California Compositions and methods of use for infusible extracellular matrix
CN121195059A (zh) * 2023-04-06 2025-12-23 株式会社Medifab 基于超临界二氧化碳工艺的水溶性脱细胞基质

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2808225C (en) * 2010-08-24 2019-02-12 The Regents Of The University Of California Compositions and methods for cardiac therapy
WO2015164728A1 (en) * 2014-04-24 2015-10-29 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Fractionating extracellular matrix to modulate bioactivity and the host response
KR101628821B1 (ko) * 2015-03-02 2016-06-13 강원대학교산학협력단 탈세포화된 생체 조직 유래의 생체적합성 가용화 스캐폴드 추출물, 이의 제조방법 및 이의 용도
US11406736B2 (en) * 2016-01-13 2022-08-09 University of Pittsburgh—Of the Commonwealth Systems of Higher Education Vascular extracellular matrix hydrogel
AU2018226871B2 (en) * 2017-03-02 2023-08-10 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Extracellular matrix (ECM) hydrogel and soluble fraction thereof for the treatment of cancer
EP3755267B1 (en) * 2018-02-22 2024-06-12 University of Pittsburgh - of the Commonwealth System of Higher Education Extracts for the regeneration of ligaments

Similar Documents

Publication Publication Date Title
Wang et al. Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel
Henning et al. Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size
Moelker et al. Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine
Hu et al. Hyaluronidase-powered microneedles for significantly enhanced transdermal delivery efficiency
HRP20220336T1 (hr) Postupak izoliranja i liofilizacije vanstaničnih vezikula
US20250127963A1 (en) Injectable anti-heart failure hydrogel with myocardial tissue repair function, preparation method and use thereof
CN115887419A (zh) 一种载药微针贴片及其应用
US20210052663A1 (en) Compositions and Methods for Treatment of Cardiovascular Disorders
US12281330B2 (en) Adaptation of hollow-fiber-based cell culture technology for the manufacturing of (1) neo-islets, employed for the treatment of type 1 and type 2 diabetes mellitus, and (2) the generation of exosomes from various cell types, used in the treatment of different organ injuries and diseases
Joshi et al. Nanofibers based tissue engineering and drug delivery approaches for myocardial regeneration
JP2022505468A5 (https=)
KR20190102011A (ko) 상피-중간엽 전이를 예방 또는 최소화하는 방법 및 조성물
CN115634363B (zh) 可溶性分层微针、鼻腔给药载体、鼻腔给药系统及制备方法
JP2024166198A (ja) 可溶性細胞外マトリックス組成物および血管内送達のための方法
KR101610732B1 (ko) 약물 전달체 및 이를 포함하는 구강건조증 치료를 위한 약학적 조성물
CN115725500A (zh) 脂肪间充质干细胞外泌体、其制备方法及其应用
EP2431046B1 (en) Use of olive leaf extracts in a pharmaceutical composition for inducing angiogenesis and vasculogenesis
JPWO2020086955A5 (https=)
KR20210057689A (ko) 유도만능줄기세포-유래 중간엽 줄기세포 전구세포로부터 유래된 엑소좀을 포함하는 신장 질환의 예방 또는 치료용 조성물
Ieishi et al. The effect of G-CSF in a myocardial ischemia reperfusion model rat
CN102429858A (zh) 缓释bio/igf的复合水凝胶的制备方法及其应用
Sawa Current status of myocardial regeneration therapy
CN101301306A (zh) Dft在制备治疗和预防休克药物中的应用
Zhou et al. Targeted Delivery of Insulin-Like Growth Factor-1 Improves Stem Cell Therapy in A Rat Myocardial Infarction Model
Afjeh-Dana et al. Cardiac Tissue Regeneration Based on Stem Cell Therapy